Shikai Wu
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 12
- HER2/EGFR in Cancer Research 11
- Cancer Treatment and Pharmacology 10
- Lung Cancer Research Studies 9
- Colorectal Cancer Treatments and Studies 8
- Cancer Research top 10%
-
- Brain Metastases and Treatment 12
- Lung Cancer Treatments and Mutations 9
- Gastric Cancer Management and Outcomes 7
- Genetics top 10%
- Journals
- Journal of Clinical Oncology (2 papers)SHILAP Revista de lepidopterología (2 papers)ACS Nano (1 paper)
- Partner nations
- ChinaUnited StatesAustria
In The Last Decade
Shikai Wu
66 papers receiving 783 citations
Peers
Comparison fields: 5 of 92
- Oncology 461
- Cancer Research 186
- Pulmonary and Respiratory Medicine 284
- Genetics 90
- Immunology 97
Countries citing papers authored by Shikai Wu
This map shows the geographic impact of Shikai Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shikai Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shikai Wu more than expected).
Fields of papers citing papers by Shikai Wu
This network shows the impact of papers produced by Shikai Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shikai Wu. The network helps show where Shikai Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shikai Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 12 | |
| 2 | 2024 | 36 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 2 | |
| 6 | 2021 | 20 | |
| 7 | 2021 | 62 | |
| 8 | 2018 | 24 | |
| 9 | 2018 | 13 | |
| 10 | 2017 | 1 | |
| 11 | 2016 | 2 | |
| 12 | 2016 | 7 | |
| 13 | 2015 | 29 | |
| 14 | [Detection of circulating tumor cells and its clinical value for different stages and various subtypes of breast cancer]. | 2014 | 3 |
| 15 | 2014 | 3 | |
| 16 | 2014 | 3 | |
| 17 | 2013 | 3 | |
| 18 | 2012 | 11 | |
| 19 | 2011 | 12 | |
| 20 | 2000 | 1 |
About Shikai Wu
Shikai Wu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics, having authored 73 papers that have together received 796 indexed citations. Recurring topics across this work include Brain Metastases and Treatment (12 papers), Cancer Immunotherapy and Biomarkers (12 papers), HER2/EGFR in Cancer Research (11 papers), Cancer Treatment and Pharmacology (10 papers), Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (9 papers), Colorectal Cancer Treatments and Studies (8 papers) and Gastric Cancer Management and Outcomes (7 papers). The work is most often cited by research in Oncology (461 citations), Cancer Research (186 citations) and Pulmonary and Respiratory Medicine (284 citations). Shikai Wu has collaborated with scholars based in China, United States and Austria. Frequent co-authors include Bing Sun, Xiangying Meng, Santai Song, Chao Liu, Yang Cong, Zefei Jiang, Shaohua Zhang, Zhou Huang, Lijuan Ding and Qinyong Hu. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.